DRUGS MADE IN AMERICA ACQUISITION II CORP.: cashflow_investing

Value{"amount": -500000000, "concept": "us-gaap:NetCashProvidedByUsedInInvestingActivities", "currency": "USD"}
Period2025-01-01 – 2025-09-30
Statuscurrent
EntityDRUGS MADE IN AMERICA ACQUISITION II CORP.
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference: 0001213900-25-112095
Retrieved: 2026-08-19T19:07:31.882959+02:00
Raw response sha256: f7bde1a401b286c74a2fd824ee1df541…
Also addressable by official identifiers: https://factanker.com/fact/sec/cik-0002040475/cashflow-investing/2025-09-30 (CIK, metric, reporting date)
Cite as: FACTANKER, https://factanker.com/fact/6aa4c8c4-9f95-4e29-ad0a-06753ed56097

History